COMPETITIVE INTELLIGENCE · ONCOLOGY-ONLY

Oncology competitive intelligence, before the landscape moves.

Prognyx turns trials, readouts, deals and regulatory moves into one sourced answer for your asset and your next decision, delivered as a five-business-day pilot. Each claim links to a primary source; automated checks remove what its source does not carry.

Registry, FDA, EMA, SEC, company releases 5 days scope-to-brief 1 focus, oncology

[ 01 ] THE PROBLEM

The field moves faster than any team can track.

01

Signal, buried.

Thousands of trials, abstracts and filings land every month. The one move that changes your strategy is in there. You just can't surface it in time.

02

Tools, not answers.

A six-figure database hands you data to mine. A consulting project hands you a deck, once. Neither watches your back on a Tuesday afternoon.

03

Priced for giants.

Enterprise intelligence is built for big-pharma budgets. The biotech with the most riding on a single asset is the one left flying blind.

Registry, FDA, EMA, SEC and company releases: the primary records a briefing links to, wherever one exists
5 days business days from agreed scope to delivered brief
1 therapeutic focus, oncology, and nothing else

[ 02 ] WHAT PROGNYX DOES

Oncology competitive intelligence, focused on one decision.

Not a portal to mine or a six-week consulting project. One asset, one indication and one decision question, researched, sourced and delivered as a concise brief.

  • Bounded. The question, evidence set and deadline are agreed before work starts.
  • Sourced. Every claim traces back to the primary record, NCT, label, abstract, filing.
  • Decision-ready. The so-what and the now-what, not a data dump.
  • Tailored. Scoped to your assets, mechanisms and indications.
COMPETITIVE BRIEF LIVE WATCH

KRAS G12C, second-line NSCLC

Competitor readoutESMO 2026
Threat levelElevated
Window to act~6 weeks
78

A rival's confirmatory data lands before your filing. Here's the angle, the risk to your positioning, and the three moves on the table.

SOURCED · ClinicalTrials.gov · ESMO abstract · FDA label

[ 03 ] HOW IT WORKS

From noise
to a decision,
in four moves.

01

Define

We map your competitive set, targets, mechanisms, indications and the assets that can move your value.

SCOPE
02

Watch

We track trials, congress readouts, regulatory actions, deals and publications, straight to the primary source.

MONITOR
03

Synthesize

We turn it into what it means for you and what to do next, sharp, sourced, no filler.

ANALYZE
04

Decide

You get briefs your team actually reads and forwards, plus answers on demand when the field shifts.

ACT

[ 04 ] WHY PROGNYX

Not a database. Not a $150k deck. Your analyst.

Prognyx Data platforms Consulting
One defined decision scope
Tailored to your pipeline
Decision-ready (the so-what)
Oncology-deep
Days, not weeks
Accessible to a single-asset biotech

We don't out-database the giants. We out-matter them on the one question they can't answer for you: what do I do about this, on my molecule, this week?

[ 05 ] FROM THE WATCHTOWER

Oncology intelligence, in the open.

All briefings →

[ 06 ] THE OFFER

See the next move first.

Tell us the asset, indication and decision you need to clarify. We will confirm the scope and fee of a one-off pilot in writing, delivered in five business days.

How Prognyx knows this

Every claim is built from primary sources only, and traces back to a document you can open. No opinion you can't check.

ClinicalTrials.gov · FDA · EMA · SEC filings · Peer-reviewed literature

Who's behind it

Rali Filali, founder of Prognyx · M.D. candidate. Independent, no platform or bank behind the read. Every brief is audited against the primary record before it reaches you. Competitive analysis of public information, not medical or investment advice.

One-off pilot, one asset, one indication and one defined decision question, delivered in five business days with one written revision, at a fixed fee confirmed in writing. See the exact scope

Need it every month? Join the waitlist for a monthly source-linked feed on one target (page, CSV and alerts). See the KRAS G12C example

ONCOLOGY COMPETITIVE INTELLIGENCE · PROGNYX